Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-Throughput MicroRNA (miRNAs) Arrays Unravel the Prognostic Role of MiR-211 in Pancreatic Cancer

14 Nov 2012

Abstract excerpt

BACKGROUND: Only a subset of radically resected pancreatic ductal adenocarcinoma (PDAC) patients benefit from chemotherapy, and identification of prognostic factors is warranted. Recently miRNAs emerged as diagnostic biomarkers and innovative therapeutic targets, while high-throughput arrays are opening new opportunities to evaluate whether they can predict clinical outcome. The present study evaluated whether...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene expression and cancer classification
Share to MicroRNA in disease regulation
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23155457
DOI: 10.1371/journal.pone.0049145

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-Throughput MicroRNA (miRNAs) Arrays Unravel the Prognostic Role of MiR-211 in Pancreatic CancerPMID 23155457Read ↗

Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomySemantic proximity Read ↗

Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significanceSemantic proximity Read ↗

MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological valueSemantic proximity Read ↗

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

The complex network of miRNA and mRNA target interactions in pancreatic cancerSemantic proximity Read ↗

Clinical Potential of MicroRNAs in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survivalSemantic proximity Read ↗

The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 clusterSemantic proximity Read ↗

MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinomaSemantic proximity Read ↗

Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancerSemantic proximity Read ↗

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.